Marchés français ouverture 3 h

Laboratory Corporation of America Holdings (LH)

NYSE - Nasdaq Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
239,99-0,95 (-0,39 %)
À la clôture : 04:00PM EDT
239,99 0,00 (0,00 %)
Échanges après Bourse : 04:31PM EDT

Laboratory Corporation of America Holdings

531 South Spring Street
Burlington, NC 27215
United States
844 625 0967
https://www.labcorp.com

Secteur(s)Healthcare
Secteur d’activitéDiagnostics & Research
Employés à temps plein75 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Adam H. SchechterPres, CEO & Chairman5,51MS.O.1965
Mr. Glenn A. EisenbergCFO & Exec. VP2,3MS.O.1961
Dr. Brian J. Caveney M.P.H., M.D., J.D., MPHExec. VP, Pres of Diagnostics & Chief Medical Officer1,57MS.O.1974
Mr. Mark S. SchroederExec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain1,59MS.O.1961
Dr. Paul R. Kirchgraber M.D.Exec. VP & CEO of Covance Drug Devel.2,02MS.O.1962
Dr. Michelle Abelson Ph.D.Laboratory Director of OperationsS.O.S.O.S.O.
Mr. Peter J. WilkinsonSr. VP & Chief Accounting OfficerS.O.S.O.1972
Mr. Lance V. BerberianExec. VP and Chief Information & Technology OfficerS.O.S.O.1963
Dr. Marcia T. Eisenberg Ph.D.Chief Scientific Officer & Sr. VPS.O.S.O.1960
Chas CookVP of Investor RelationsS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2021 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations. It offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Laboratory Corporation of America Holdings en date du 1 juillet 2022 est 1. Les scores principaux sont Audit : 8; Société : 7; Droits des actionnaires : 1; Compensation : 1.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.